How effective are access, provider, system and societal interventions in increasing the uptake of influenza vaccination in people aged 60 years and older in the community?
Trials did not report adverse events. There were no trials of interventions at a societal level. A key problem was measuring how complete the assessment of influenza vaccination was, as in most of the US studies it was possible for participants to receive vaccination at walk-in clinics and during campaigns, instead of their regular clinics; some studies did not perform independent verification of the accuracy and completeness of their clinic records or financial billings.
Many health authorities recommend influenza vaccination of older people. However, vaccination uptake in people aged 60 and older varies across countries, socioeconomic and health-risk groups. It is important to identify effective interventions to increase influenza vaccination uptake.